home *** CD-ROM | disk | FTP | other *** search
/ Cancer - Principles & Practice of Oncology / Oncology.iso / PPO / CHAP53 / T4_3A.GIF < prev    next >
Graphics Interchange Format  |  1999-06-07  |  273.6 KB  |  968x740  |  8-bit (240 colors)
   ocr: Drug Mechanism of Injury Histopathology Clinical Fealures Chest Roenigenogram Diagnosis Treatment ALKYLATING AGENTS No studies, but direct Pneumocyte dysplasia 4% incidence; no direct dosc- Most common bibasilar Suggested by history Withdrawal of the drug: anecdotal Busulfan toxicity to cpithelial (degeneration of dependent toxicity; may he reticular pattern; rarely and bizarre reports of improvement with (Myleran)38.1012-1 lining suggested cells is type hyperplastic Icells; type atypical II radiation threshold and dose other (>500 mg); pleural pulmonary effusion, ossification, sputum pneumocy ...